Shares in Novo Nordisk, one of Europe’s largest listed companies, slumped on Monday after the company said that one of its diabetes drugs had failed to slow the progression of Alzheimer’s in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback